{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:31:30Z","timestamp":1793377890111,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejso.2026.111973","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:35:24Z","timestamp":1782372924000},"page":"111973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of body composition parameters with pathological response to neoadjuvant immunochemotherapy in locally advanced gastric cancer"],"prefix":"10.1016","volume":"52","author":[{"given":"Xinglong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2437-2138","authenticated-orcid":false,"given":"Liang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2026.111973_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.ejso.2026.111973_bib2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jso.25220","article-title":"Comparison of gastric cancer survival after R0 resection in the US and China","volume":"118","author":"Li","year":"2018","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111973_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cac2.12516","article-title":"The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer","volume":"44","author":"Wang","year":"2023","journal-title":"Cancer Commun (Lond)"},{"issue":"26","key":"10.1016\/j.ejso.2026.111973_bib4","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.20.02914","article-title":"PRODIGY: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer","volume":"39","author":"Kang","year":"2021","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.111973_bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1470-2045(21)00297-7","volume":"22","author":"Zhang","year":"2021","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111973_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1200\/JCO.22.00686","article-title":"Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in localized deficient mismatch repair\/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma: the GERCOR NEONIPIGA phase II study","volume":"41","author":"Andr\u00e9","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111973_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.783243","article-title":"Safety and efficacy of camrelizumab in combination with nab-paclitaxel plus S-1 for the treatment of gastric cancer with serosal invasion","volume":"12","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111973_bib8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/cancers14041054","article-title":"The new era of immunotherapy in gastric cancer","volume":"14","author":"Takei","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10294","key":"10.1016\/j.ejso.2026.111973_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejso.2026.111973_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jjco\/hyaa202","article-title":"Current status of immunotherapy for advanced gastric cancer","volume":"51","author":"Kawazoe","year":"2021","journal-title":"Jpn J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.111973_bib11","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s12094-024-03437-0","article-title":"Current status of neoadjuvant immunotherapy for the treatment of gastric cancer","volume":"26","author":"Zhang","year":"2024","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111973_bib12","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/ncp.10473","article-title":"Dose-response meta-analysis of the impact of body mass index on mortality in the intensive care unit","volume":"35","author":"Khalooeifard","year":"2020","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.ejso.2026.111973_bib13","doi-asserted-by":"crossref","DOI":"10.18203\/2349-3259.ijct20201052","article-title":"Investigation on nutrition status and clinical outcome of patients with common cancers in Chinese patients: a multicenter prospective study protocol","volume":"7","author":"Xu","year":"2020","journal-title":"Int J Clin Trials"},{"issue":"suppl_2","key":"10.1016\/j.ejso.2026.111973_bib14","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1093\/annonc\/mdx815","article-title":"Insulin resistance and body composition in cancer patients","volume":"29","author":"Dev","year":"2018","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.111973_bib15","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1245\/s10434-018-6624-1","article-title":"Marked loss of muscle, visceral fat, or subcutaneous fat after gastrectomy predicts poor survival in advanced gastric cancer: single-center study from the CLASSIC trial","volume":"25","author":"Park","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2026.111973_bib16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11864-023-01122-y","article-title":"Gastric cancer with sarcopenia: an area worth focusing on","volume":"24","author":"Xie","year":"2023","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111973_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jcsm.12484","article-title":"Prognostic role of body composition parameters in gastric\/gastroesophageal junction cancer patients from the EXPAND trial","volume":"11","author":"Hacker","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"10.1016\/j.ejso.2026.111973_bib18","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1016\/j.clnu.2021.06.021","article-title":"Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: a multicenter, international study","volume":"40","author":"Lin","year":"2021","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.ejso.2026.111973_bib19","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/jcsm.12793","article-title":"Prognostic significance of surgery-induced sarcopenia in the survival of gastric cancer patients: a sex-specific analysis","volume":"12","author":"Lee","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejso.2026.111973_bib20","article-title":"Identification of differences in body composition measures using 3D-Derived artificial intelligence from multiple CT scans across the L3 vertebra compared to a single mid-point L3 CT scan","volume":"2023","author":"Cao","year":"2023","journal-title":"Radiol Res Pract"},{"issue":"1","key":"10.1016\/j.ejso.2026.111973_bib21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1186\/s12885-025-13766-0","article-title":"Incidence and risk factors of sarcopenia in gastric cancer patients: a meta-analysis and systematic review","volume":"25","author":"Fu","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2026.111973_bib22","article-title":"Efficacy prediction of neoadjuvant cadonilimab plus FLOT therapy for advanced gastric cancer: a study based on body composition changes","volume":"15","author":"Liu","year":"2025","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111973_bib23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"issue":"12","key":"10.1016\/j.ejso.2026.111973_bib24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.111973_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies","volume":"14","author":"Batsis","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111973_bib26","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/jcsm.12575","article-title":"Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis","volume":"11","author":"Lee","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.ejso.2026.111973_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.6004\/jnccn.2025.0022","article-title":"Gastric cancer, version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Ajani","year":"2025","journal-title":"J Natl Compr Cancer Netw"},{"issue":"7","key":"10.1016\/j.ejso.2026.111973_bib28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3390\/jcm10071361","article-title":"Progressive sarcopenia correlates with poor response and outcome to immune checkpoint inhibitor therapy","volume":"10","author":"Loosen","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejso.2026.111973_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1061044","article-title":"Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111973_bib30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jcsm.12848","article-title":"Percentile-based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels","volume":"13","author":"Marquardt","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.ejso.2026.111973_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/apha.12224","article-title":"Measurement of skeletal muscle radiation attenuation and basis of its biological variation","volume":"210","author":"Aubrey","year":"2014","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.ejso.2026.111973_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109340","article-title":"Impact of CT-based body composition parameters at baseline, their early changes and response in metastatic cancer patients treated with immune checkpoint inhibitors","volume":"133","author":"Cromb\u00e9","year":"2020","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111973_bib33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jcsm.13073","article-title":"Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies","volume":"14","author":"Martin","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"10.1016\/j.ejso.2026.111973_bib34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1159\/000520096","article-title":"Muscle mass and inflammation in older adults: impact of the metabolic syndrome","volume":"68","author":"Buchmann","year":"2022","journal-title":"Gerontology"},{"issue":"2","key":"10.1016\/j.ejso.2026.111973_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jcsm.12267","article-title":"Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer","volume":"9","author":"Daly","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326005925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326005925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:35:10Z","timestamp":1793374510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326005925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0748798326005925"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111973","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of body composition parameters with pathological response to neoadjuvant immunochemotherapy in locally advanced gastric cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111973"}}